Pain

MD IQ

Conference Coverage

Tanezumab acts fast for OA pain relief

TORONTO – The nerve growth factor inhibitor separated from placebo in the first 3-5 days in a phase 3 randomized, controlled trial.

ECG Challenge

Hanging by a Thread

Even a heart attack wouldn’t stop this 54-year-old man from working. But a rock-climbing injury has knocked him off course. Will your preoperative...

Pages